Low proliferation capacity of lymphocytes from alloxan-diabetic rats: Involvement of high glucose and tyrosine phosphorylation of Shc and IRS-1

Life Sciences

Volumn 71, Issue 23, 2002, Pages 2759-2771

  Otton, Rosemari ^a   Carvalho, Carla R O ^a   Mendonça, José R ^a   Curi, Rui ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Insulin; IRS 1; Lymphocyte; Proliferation; Shc; Tyrosine phosphorylation

Indexed keywords

CONCANAVALIN A; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LIPOPOLYSACCHARIDE; PROTEIN SHC;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MESENTERY LYMPH NODE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; TIME;

ALLOXAN; ANIMALS; CELL DIVISION; CULTURE MEDIA; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; INSULIN; LYMPHOCYTES; MALE; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEINS; RATS; RATS, WISTAR; TYROSINE; VIRAL PROTEINS;

EID: 0037175059     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02141-0     Document Type: Article

References (56)

1. Maccuish A.C., Urbaniak S.J., Campbell C.J., Duncan L.J.P., Irvine W.J. Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes. 23:1974;708-712.
2. Pallavicini M.G., William K.N. Inhibition of lymphocyte blastogenesis by factor(s) in alloxan-diabetic rat plasma. Diabetes. 25:1976;614-622.
3. Mandel M.A., Mahmoud A.A.F. Impairment of cell-mediated immunity in mutation diabetic mice (db/db). Journal of Immunology. 120:1978;1375-1377.
4. Yokono K., Kawase Y., Nagata M., Hatamori N., Baba S. Supression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse. Diabetologia. 32:1989;67-73.
5. Rayfield E.J., Ault M.J., Keusch G.T., Brothers M.J., Nechemias C., Smith H. Infection and diabetes: the case for glucose control. American Journal of Medicine. 72:1982;439-450.
6. Reinhold D., Ansorge S., Schleicher D. Elevated glucose levels stimulate transforming growth factor-β1 (TGF-β1), suppressess interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Hormone and Metabolic Research. 28:1996;267-270.
7. von Kanel R., Mills P.J., Dimsdale J.E. Short-term hyperglycemia induces lymphopenia and lymphocytes subset redistribution. Life Sciences. 69:2001;255-262.
8. Tian J., Zekzer D., Hanssen L., Lu Y., Olcott A., Kaufman D.L. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. Journal of Immunology. 167:2001;1081-1089.
9. Robey E., Allison J.P. T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunology Today. 16:1995;303-310.
10. Yaqoob P., Calder P.C. Glutamine requirement of proliferating T lymphocytes. Nutrition. 13:1997;646-651.
11. Tong-Rong J., Kaminski N.E. Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol. Journal of Leukocyte Biology. 69:2001;841-849.
12. Brand K., Aichinger S., Forster S., Kupper S., Neumann B., Nurnberg W., Ohrish G. Cell-cycle-related metabolic and enzymatic events in proliferating rat thymocytes. European Journal of Biochemistry. 172:1988;695-702.
13. Izquierdo Pastor M., Reif K., Cantrell D. The regulation and function of p21 ras during T-cell activation and growth. Immunology Today. 16:1995;159-164.
14. Wagle A., Jivraj S., Garlock G.L., Stapleton S.R. Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phophatidylinositol 3-kinase. Journal of Biological Chemistry. 24:1998;14968-14974.
15. Baldari C.T., Telford J.L. Lymphocyte antigen receptor signal integration and regulation by the Shc adaptor. Journal of Biological Chemistry. 380:1999;129-134.
16. Reusch J.E., Bhuripanyo P., Carel K., Leitner J.W., Hsieh P., DePaolo D., Draznin B. Differential requirement for p21ras activation in the metabolic signaling by insulin. Journal of Biological Chemistry. 270:1995;2036-2040.
17. Pawson T. Protein modules and signaling networks. Nature. 373:1995;573-580.
18. Wary K.K., Mainiero F., Isakoff S.J., Marcantonio E.E., Giancotti F.G. The adaptor protein shc couples a class of integrins to the control of cell cycle progression. Cell. 87:1996;733-743.
19. Sesti G. Insulin receptor substrate polymorphisms and type 2 diabetes mellitus. Pharmacogenomics. 1:2000;343-357.
20. Wang L.M., Myers M.G., Sun X.J., Aaronson S.A., White M., Pierce J.H. IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoeitic cells. Science. 261:1993;1591-1594.
21. Pereira B., Costa Rosa L.F.B., Safi D.A., Bechara E.J.H., Curi R. Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs of diabetic rats. Journal of Endocrinology. 142:1994;161-165.
22. Trinder R. Determination of glucose in blood using glucose oxidase with alternative oxygen acceptor. Annals of Clinical Biochemistry. 6:1969;24-27.
23. Curi R., Newsholme P., Newsholme E.A. Metabolism of pyruvate by isolated rat mesenteric lymphocyte, lymphocyte mitochondria and isolated mouse macrophages. Biochemical Journal. 250:1988;383-388.
24. Ardawi M.S.M., Newsholme E.A. Glutamine metabolism in lymphocytes of the rat. Biochemical Journal. 212:1983;835-842.
25. Miyasaka C.K., Mendonca J.R., Nishiyama A., de Souza J.A., Pires de Melo M., Pithon-Curi T.C., Curi R. Comparative effects of fish oil given by gavage and fish oil-enriched diet on leukocytes. Life Sciences. 31(69):2001;1739-1751.
26. Otton R., Graziola F., Souza J.A.A., Curi T.C.P., Hirata M.H., Curi R. Effect of dietary fat on lymphocyte proliferation and metabolism. Cell Biochemistry and Function. 16:1998;253-259.
27. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry. 72:1976;248-254.
28. De Maria R., Todaro M., Stassi G., Blasi F., Giordano M., Galluzo A., Giordano A. Defective T cell receptor/CD3 complex signaling in human type I diabetes. European Journal of Immunology. 24:1994;999-1002.
29. Ohno Y., Aoki N., Nishimura A. In-vitro production of interleukin-1, interleukin-6 and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism. 77:1993;1072-1077.
30. Reinhold D., Bank U., Hling F.B., Lendeckel U., Ansorge S. Transforming growth factor β1 (TGF-β1) inhibits IL-10 mRNA-expression and IL-10 production in PWM-stimulated PBMC and T-cells. Journal of Interferon and Cytokine Research. 15:1995;685-690.
31. Field C.J., Wu G., Metroz-Dayer M.D., Montambault M., Marliss E.B. Lactate production is the major metabolic fate of glucose in splenocytes and is altered in spontaneously diabetic bb rats. Biochemical Journal. 272:1990;445-452.
32. Conroy S.J., Abdel-Wahab Y.H.A., Caraher E.M., Byrne P.M., Murphy E., Nolan J., Flatt P.R., Newsholme P. Evidence for complement-dependent and -independent inhibition of insulin secretion from clonal B-cells incubated in the presence of sera of newly diagnosed IDDM patients. Journal of Endocrinology. 164:2000;139-147.
33. Cooper E.H., Barkhman P., Hale A.J. Observations on the proliferation of human leukocytes cultured with phytohaemagglutinin. British Journal of Haematology. 9:1963;101-111.
34. Culvenor J., Weideman M.J. Phytohaemagglutinin stimulation of rat thymus lymphocyte glycolysis. Biochimica et Biophysica Acta. 437:1976;354-363.
35. Licastro F., Davis L.J., Morini M.C. Lectins and superantigens-membrane interactions of these compounds with T-lymphocytes affect immune responses. International Journal of Biochemistry. 25:1993;845-852.
36. Antal-Szalmas P. Evaluation of CD14 in host defense. European Journal of Clinical Investigation. 30:2000;167-179.
37. Ziegler-Heitbrock H.W., Ulevitch R.J. CD14: cell surface receptor and differantiation factor. Immunology Today. 14:1993;121-125.
38. Nishiyama A., Cavaglieri C.R., Curi R., Calder P.C. Arachidonic acid-containing phophatidylcholine inhibits lymphocyte proliferation and decreases interleukin-2 and interferon-γ production from concanavalin A-stimulated rat lymphocytes. Biochimica et Biophysica Acta. 1487:2000;50-60.
39. Altman A., Mustelin T., Coggeshall M. T lymphocyte activation: a biological model of signal transduction. Immunology. 10:1990;347-391.
40. DeFranco A.L. Molecular aspects of B-lymphocyte activation. Annual Review of Cell Biology. 3:1987;143-178.
41. Nervi S., Atlan-Gepner C., Fossat C., Vialettes B. Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways. Journal of Autoimmunity. 13:1999;247-255.
42. Woda B.A., Padden C. Mitogen responsiveness of lymphocytes from the BB/W rat. Diabetes. 35:1986;513-516.
43. Snow E.C., Feldbush T.L., Oaks J.A. The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro. Journal of Immunology. 124:1980;739-744.
44. Hollenberg M.D., Cuatrecasas P. Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake. Journal of Biological Chemistry. 250:1975;3845-3850.
45. Vaheri A., Ruoslahti E., Hovi T., Nordling S. Stimulation of density-inhibited cell cultures by insulin. Journal of Cell Physiology. 81:1973;355-360.
46. Gospodarowics D., Moran J.S. Stimulation of division of spare and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulin. Proceedings of National Academy of Sciences. 71:1974;4584-4590.
47. Kahn C.R., White M.F., Shoelson S.E., Backer J.M., Araki E., Cheatham B., Csermely P., Folli F., Golstein B.J., Hfuertas P. The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Progress in Hormone Research. 48:1993;291-339.
48. Myers M.G., White M.F. Insulin signal transduction and the IRS proteins. Annual Review of Pharmacology and Toxicology. 36:1996;615-658.
49. Lavan B.E., Lane W.S., Lienhard G.E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. Journal of Biological Chemistry. 272:1997;11439-11443.
50. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., Lanfrancone L., Pelicci P.G. The p66 shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 402:1999;309-313.
51. Ravichandran K., Lee K.K., Songyang Z., Cantley L.C., Burn P., Burakoff S.J. Interaction of Shc with the ζ chain of the T cell receptor upon T cell activation. Science. 262:1993;902-905.
52. Ravichandran K.S., Lorenz U., Shoelson S.E., Burakoff S.J. Interaction of Shc with Grb2 regulates association of Grb2 with SoS. Molecular and Cellular Biology. 15:1995;593-598.
53. Shpakov A.O., Pertseva M.N. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effectors proteins. Molecular and Cellular Biology. 13:2000;455-584.
54. Wolf G., Sharma K., Chen Y., Ericksen M., Ziyadah F.N. High glucose proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney International. 42:1992;647-656.
55. Kolm B., Olgemoller B., Sauer U., Schleicher E. High glucose-induced transforming growth factor β1 regulates mesangial matrix production of heparan sulfate proteoglycan. American Journal Physiology. 270:1996;812-821.
56. Reinhold D., Bank U., Buhling F., Lendeckel U., Ulmer A.J., Flad H.D., Ansorge S. Transforming growth factor β1 (TGFβ1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of Il-2, IL-6 production. Cytokine. 6:1994;382-388.